July 9, 2021
“Aerpio Pharmaceuticals (ARPO) is a biopharmaceutical company focused on developing compounds that activate Tie2. Tie2 is considered a key regulator of vascular stability, and ARPO “believes that activation of Tie2 may have therapeutic potential” for different indications. In Q1, ARPO… Continue Reading…
July 7, 2021
“BioHiTech Global, Inc. (BHTG)… In line with these comments, Dayal rates the stock as a Buy, and his $4 price target implies robust growth of 181% for the next 12 months. Dayal’s review is the only one file for BHTG shares,… Continue Reading…
July 7, 2021
“Mehta outlined 10 oil stocks he is bullish on in a new piece of research on Tuesday: (1) Occidental Petroleum (OCY); (2) ExxonMobil (XOM); (3) Ovintiv (OVV); (4) Diamondback Energy (FANG); (5) ConocoPhillips (COP); (6) EQT Corporation (EQT); (7) Pioneer… Continue Reading…
July 2, 2021
“Futures contracts tied to the major U.S. stock indexes rose slightly on Friday as the June jobs report beat expectations, putting Wall Street on track to post a solid week of gains across the board. Contracts tied to the Dow… Continue Reading…
July 1, 2021
“On Wednesday, Robinhood reached a settlement with FINRA over a multitude of issues, agreeing to pay a fine of $57 million and restitution to customers of $12.6 million. In the 122-page settlement document against Robinhood, FINRA explains that the company “has paid or intends… Continue Reading…
June 30, 2021
“…”We view GE as the ultimate self-help, re-opening levered story in Industrials,” said Goldman Sachs analyst Joe Ritchie in a new research note on Tuesday. The analyst slapped a $16 price target on GE’s stock, representing about a 22% upside… Continue Reading…
June 30, 2021
“Pending home sales, a measure of signed contracts on existing homes, jumped an unexpectedly high 8% in May compared with April, according to the National Association of Realtors. Analysts expected a 1% drop. This is the highest level of sales… Continue Reading…
June 29, 2021
“Day One Biopharmaceuticals (DAWN)… Overall, there is broad agreement on Wall Street with Rama’s view, as indicated by the unanimous Strong Buy consensus rating, supported by 4 recent positive reviews. Shares in DAWN are selling for $20.11 and their $37.33 average… Continue Reading…
June 29, 2021
“NIO (ticker: NIO) stock gained almost 10% Monday and shares are up 28% over the past month. The S&P 500, for comparison, rose 0.2% Monday and is up 2% over the past month. Call options volume, which rose almost 200% on Monday… Continue Reading…
June 28, 2021
“On Saturday, the company released interim data from the Phase 1 trial of its collaboration with Regeneron on an experimental therapy for transthyretin amyloidosis (ATTR) – a protein misfolding disorder… While it is still early days, Issi calls the data… Continue Reading…
Recent Comments